Displaying 1–9 of 9 results for Alkermes, Inc
Alkermes' Aristada (aripiprazole lauroxil) extended release injection is approved to treat adults with schizophrenia
Recro acquisition includes worldwide rights to IV/IM meloxicam and contract manufacturing facility in Gainesville, Georgia
Along with the facility, the manufacturing and royalty revenue associated with products made at the facility will be sold to Recro Pharma Inc.
Anything from excess moisture to variable API loading can affect tablet quality. PAT methods and equipment innovations can reduce variability.
This case study demonstrates a large pharmaceutical contract manufacturing engagement in which there has been ﬁve years trouble free supply with OTIF (On-Time-InFull) consistently >95%.
This case study demonstrates the successful transfer of a low solubility compound into one of our manufacturing sites and achieving as a result, an OTIF (On-Time-InFull) consistently over 95%.
Outsourcing is no longer a tactical decision but rather a partner-driven strategic activity. This paper presents essential success factors in fostering and maintaining long-term partnerships in pharmaceutical outsourcing. After completing the registration form you will have access to download the...
With the number of diabetes patients steadily rising, the race to replace conventional needles for insulin delivery becomes all the more important, and lucrative. Clear leaders are emerging, but there have been few real successes and many documented failures.